Private Capital's DGX Position Overview
Private Capital (via Private Capital Management, LLC) currently holds 8,700 shares of Quest Diagnostics Incorporated (DGX) worth $1.71 M, representing 0.17% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Private Capital has maintained a strategic position in DGX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 2,700 shares. Largest reduction occurred in Q2 2025, reducing 2,000 shares.
Analysis based on 13F filings available since 2013 Q2
Private Capital's Quest Diagnostics Incorporated (DGX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Quest Diagnostics Incorporated (DGX) Trades by Private Capital
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +300 | Add 3.57% | 8,700 | $190.58 |
| Q2 2025 | -2,000 | Reduce 19.23% | 8,400 | $179.63 |
| Q4 2024 | +1,700 | Add 19.54% | 10,400 | $150.86 |
| Q3 2024 | +500 | Add 6.10% | 8,700 | $155.25 |
| Q1 2024 | +2,000 | Add 32.26% | 8,200 | $133.11 |
| Q4 2023 | +1,000 | Add 19.23% | 6,200 | $137.88 |
| Q3 2023 | +2,700 | Add 108.00% | 5,200 | $121.86 |
| Q2 2023 | -1,000 | Reduce 28.57% | 2,500 | $140.56 |
| Q1 2023 | +1,100 | Add 45.83% | 3,500 | $141.48 |
| Q3 2022 | +2,400 | New Buy | 2,400 | $122.50 |
Private Capital's Quest Diagnostics Incorporated Investment FAQs
Private Capital first purchased Quest Diagnostics Incorporated (DGX) in Q3 2022, acquiring 2,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Private Capital has held Quest Diagnostics Incorporated (DGX) for 15 quarters since Q3 2022.
Private Capital's largest addition to Quest Diagnostics Incorporated (DGX) was in Q3 2023, adding 5,200 shares worth $633,672.
According to the latest 13F filing for Q1 2026, Private Capital's firm, Private Capital Management, LLC, owns 8,700 shares of Quest Diagnostics Incorporated (DGX), valued at approximately $1.71 M.
As of the Q1 2026 filing, Quest Diagnostics Incorporated (DGX) represents approximately 0.17% of Private Capital's publicly disclosed stock portfolio, making it one of their key holdings.
Private Capital's peak holding in Quest Diagnostics Incorporated (DGX) was 10,400 shares, as reported at the end of Q4 2024.